These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6384945)

  • 1. Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia.
    Rapp RP; Young B; Foster TS; Tibbs PA; O'Neal W
    Pharmacotherapy; 1984; 4(4):211-5. PubMed ID: 6384945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
    Cone LA; Woodard DR; Stoltzman DS; Byrd RG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):33-6. PubMed ID: 3899005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.
    Gold R; Overmeyer A; Knie B; Fleming PC; Levison H
    Pediatr Infect Dis; 1985; 4(2):172-7. PubMed ID: 3885181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli.
    Sheftel TG; Mader JT
    Antimicrob Agents Chemother; 1986 Jan; 29(1):112-5. PubMed ID: 3524419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS; Cocchetto DM
    Clin Ther; 1986; 9(1):123-34. PubMed ID: 3545476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost comparison of ceftazidime versus tobramycin/ticarcillin therapy in three hospitals.
    Parr MD; Hansen LA; Rapp RP
    Drug Intell Clin Pharm; 1988; 22(7-8):628-31. PubMed ID: 3046892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia.
    Mandell LA; Nicolle LE; Ronald AR; Landis SJ; Duperval R; Harding GK; Robson HG; Feld R; Vincelette J; Fong I
    J Antimicrob Chemother; 1987 Jul; 20(1):95-107. PubMed ID: 3305464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
    Beuscart C; Leroy O; Mouton Y; Pappo M; Drugeon H
    Pathol Biol (Paris); 1989 May; 37(5):496-9. PubMed ID: 2674875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
    Kljucar S; Heimesaat M; von Pritzbuer E; Olms K
    Infection; 1987; 15 Suppl 4():S185-91. PubMed ID: 3312032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients.
    Reilly JT; Brada M; Bellingham AJ; Hart CA; Bennet C
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():89-92. PubMed ID: 6352660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.
    Joshi M; Bernstein J; Solomkin J; Wester BA; Kuye O
    J Antimicrob Chemother; 1999 Mar; 43(3):389-97. PubMed ID: 10223595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effectiveness of ceftazidime and cefazolin/tobramycin in patients with inflammatory diseases of the lower respiratory tract].
    Vetter N; Feist H; Armbruster C; Drlicek M
    Infection; 1987; 15 Suppl 4():S192-4. PubMed ID: 3312033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
    Mackie MJ; Reilly JT; Purohit S; Bartzokas CA
    J Antimicrob Chemother; 1986 May; 17 Suppl C():219-24. PubMed ID: 3522529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
    Hartenauer U; Weilemann LS; Bodmann KF; Ritzerfeld WW; Asmus S; Koch EM
    J Hosp Infect; 1990 Apr; 15 Suppl A():61-4. PubMed ID: 1971647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.
    Rubinstein E; Lode H; Grassi C
    Clin Infect Dis; 1995 May; 20(5):1217-28. PubMed ID: 7620002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of the combination of Timentin and tobramycin in the treatment of patients with bacteraemia.
    Degener JE; Wagenvoort JH; Dzoljic-Danilovic G; Michel MF; Brus-Weijer A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():141-8. PubMed ID: 3636329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B; Berman SJ; Geckler RW; Farkas SA
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
    Mouton Y; Beuscart C; Leroy O; Pappo M; Drugeon H
    Presse Med; 1988 Oct; 17(37):1928-32. PubMed ID: 2973588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP; Miller MG; Ramsden C; Littlewood JM
    Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.